Senegal

Areas eligible for SMC and areas where SMC is implemented in 2021

Photo: SMC eligible areas in Senegal

Senegal 2021 SMC season

# of children targeted

# of children reached

Coverage

Cycle 1

50,763

47,072

93%

Cycle 2

836,975

740,928

89%

Cycle 3

836,975

747,844

89%

Cycle 4

836975

754444

90%

Children receiving at least 4 cycles

836975

754444

90%

Monitoring of coverage completeness

Photo: Women in the Sahel

Monitoring completeness of the coverage

  •  Monitoring of performance indicators (evaluation of deviations)
  •   Quick survey
  •   Supervision at all levels
  •   Daily debriefing with regional teams
  •   Development of a SMC bulletin
     

Monitoring for compliance

  • 3-day directly observed treatment across all districts
  • Systematic notification on management tools
  • Indirect evaluation by the refusal rate
     

Monitoring effectiveness

  • Setting of performance indicators at all levels
  • Morbi-Mortality assessment for children 0-120 months in SMC zones
  • Comparison with 2018 data (year without SMC)
  • Impact assessment from 2012 to 2016

Successes, opportunities, challenges and solutions in the 2020 SMC season

Successes and lessons learnt

  • Holding upstream of preparatory meetings for defining roles and responsibilities for different players for the implementation of SMC
  • Implementing partners can be a value added to the implementation but it is fundamental that the NMCP remains the lead (coordination and management)
  • The flexibility of lenders to provide additional resources for meetings (emergency between Neema , RSS +, PMI and NMCP for support with the purchase of protective equipment, not provided for in the planning
  • Sharing information early on has helped to anticipate the difficulties and arrange for better performance
  • Use of platforms for coordination (alert system) in time real and between headquarters and the regional offices allowed for faster implementation.
  • The right choice of community health workers and experience and capacity to intervene in their domain facilitates the work
  • Training for managing undesirable effects
  • Awareness before campaign facilitates community support
  •  The participation of local stakeholders (BG and Relais) promotes community involvement
  • Maintaining safety stock avoids stock-outs and delays.
  • Timely Delivery is required.
  • Notification of effects undesirable on the cards, and in SMC model, facilitates transmission to Pharmacovigilance center for accountability
  • Improved notification by DOT approach
  • Digital app for managing undesirable effects
  • The commitment of administrative authorities, nuns and elected officials in some districts facilitated implementation.

Challenges

  • Starting communication on SMC 1 month before implementation
    Developing a map of case refusals in districts and regions concerned
  • Revise the budget envelope to adapt it to the covid-19 context
  • Make physical inventories of medication, after each cycle, to allow for a good estimate of needs at next cycle

Research priorities for 2020

  • Study on the evaluation of the performance of 3 CPS doses in children aged 3-120 months in the regions concerned
  • Cost-effectiveness analysis of SMC using a Directly observed Therapy (DOT) method for 3 days  "

Partners

  • OPT-SMC